Genus PLC (GNS)

Industry Biotechnology


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

2,500.00p

Buy

2,510.00p

arrow-down-65.00p (-2.54%)

Prices updated at 12 Dec 2025, 17:00 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Genus PLC focusses on the healthcare sector. It specializes in providing genetic products intended for animals, which allow farmers to produce an enhanced quality of milk products.

Income statement

20242025
669m673m
179m204m
31m51m
4.647.61
8m19m
74m94m
Sales, General and administrative109m120m
Interest expenses21m21m
Provision for income taxes3m9m
Operating expenses148m153m
Income before taxes6m29m
Net income available to common shareholders8m19m
-0.0620.293
Net interest income-18m-19m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-0.0620.289
Free cash flow per share0.07710.7271
Book value/share8.34527.1688
Debt equity ratio0.5258790.52447

Balance sheet

20242025
Current assets271m254m
Current liabilities151m131m
Total capital776m692m
Total debt291m266m
Total equity548m476m
Total non current liabilities--
Loans228m216m
Total assets1,029m899m
Total liabilities--
Cash and cash equivalents43m48m
Common stock66m66m

Cash flow

20242025
Cash at beginning of period36m43m
Cash dividends paid-21m-21m
5m49m
Investments (gains) losses-19m-14m
43m48m
Net income--
30m67m
-25m-19m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.